In the second experiment, we looked at similar associations in thirty individuals with chronicschizophrenia.
2
Global gray matter volume has been reported to progressively decrease in childhood-onset and chronicschizophrenia.
3
Effectiveness of antipsychotic drugs in patients with chronicschizophrenia.
4
Nevertheless, findings indicate that nearly all cognitive deficits are comparably impaired across recent-onset and chronicschizophrenia.
5
These findings suggest that serum BDNF levels in chronicschizophrenia under antipsychotic medication may be decreased.
6
Previous studies in chronicschizophrenia were less conclusive.
7
These data provide evidence for diffuse and far-reaching deficits in a majority of outpatients with chronicschizophrenia.
8
Objective: To compare progressive changes in lateral ventricular size in chronicschizophrenia patients with good and poor outcomes.
9
He now suffers from chronicschizophrenia.
10
Previous research has identified altered effort allocation in chronicschizophrenia, but produced mixed results regarding its relationship with amotivation.
11
Results: In both species, ketamine induced a robust increase in PFC-HC coupling, in contrast to findings in chronicschizophrenia.
12
In the chronicschizophrenia study, there were no significant associations between regional grey matter volume and measures of insight.
13
The residual type of chronicschizophrenia with predominant negative symptoms (NS) has never been investigated for SoA.
14
The results showed that BDNF-like immunoreactivity were significantly lower in medicated patients with chronicschizophrenia than in healthy control subjects.
15
Conclusions: Volumes of the putamen may represent a longitudinal marker of treatment responsiveness and outcome in patients with chronicschizophrenia.
16
Previous research using MRI scans has shown reduced hippocampal volumes in chronicschizophrenia and first-episode psychosis compared to well subjects.